Physician profile
Robert H Page
NPI 1851398069
$4,363.15
in general payments reported to CMS, 2019-2025
45 companies · $437 in 2025
The $437 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $987 · 2020: $181 · 2021: $717 · 2022: $985 · 2023: $657 · 2024: $399 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,492.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $664.23 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $408.56 | 2019-2023 | Jardiance |
| Glaxosmithkline, LLC. | $316.34 | 2019-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Novo Nordisk INC | $290.16 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $275.93 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $247.09 | 2022-2025 | |
| Lilly USA, LLC | $226.48 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $164.85 | 2019-2023 | Farxiga |
| Sanofi-Aventis U.S. LLC | $149.41 | 2019-2023 | |
| Abbott Laboratories | $135.71 | 2022-2025 | Proclaim, Freestyle Libre 3, Confirm Rx |
| Lucid Diagnostics INC. | $100.54 | 2021 | |
| Mylan Specialty L.P. | $98.32 | 2020-2024 | Yupelri |
| Novartis Pharmaceuticals Corporation | $98.11 | 2019-2022 | |
| Amgen INC. | $95.59 | 2019-2025 | Krystexxa |
| Takeda Pharmaceuticals U.S.A., INC. | $92.48 | 2019-2022 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Page listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.